AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿ“ฐ Latest breakthroughs
๐Ÿ—บ๏ธ Disease Atlas ยท Gastrointestinal disease

oral submucous fibrosis

Oral submucous fibrosis (OSMF) is a chronic, progressive disease that alters the fibroelasticity of the oral submucosa, prevalent in India and Southeast Asia but rare elsewhere, and characterized by burning and pain in the oral cavity, loss of gustatory sensation, the presence of blanched fibrous bands and stiffening of the oral mucosa and oro-pharynx (leading to trismus and a progressive reduction in mouth opening)โ€ฆ

๐Ÿ”” Follow weekly
๐Ÿงฌ576genes / proteins with evidence
๐Ÿ’Š6drugs and clinical candidates
๐Ÿงช2recruiting trials worldwide
โœ…3phase 3
๐Ÿ“ˆ2phase 1/2
๐Ÿ”ฌ

Understand oral submucous fibrosis

Every other disease ยท Genes, environment and time
๐ŸŽ“ Learn more

What it is

Oral submucous fibrosis (OSMF) is a chronic, progressive disease that alters the fibroelasticity of the oral submucosa, prevalent in India and Southeast Asia but rare elsewhere, and characterized by burning and pain in the oral cavity, loss of gustatory sensation, the presence of blanched fibrous bands and stiffening of the oral mucosa and oro-pharynx (leading to trismus and a progressive reduction in mouth opening) and an increased risk of developing oral squamous cell cancer (3-19%). It is usually associated with the chewing of the areca nut (an ingredient in betel quid) but the exact etiology is unknown and there is currently no effective treatment.

From the Open Targets disease record โ†—

๐Ÿ”ฌ Every other disease: Most diseases come from a mix of the genes we inherit, the environment and way we live, and the passing of time.

โ“ Why it happens

  • Genes can make a person more or less likely to get a disease.
  • Environment and lifestyle - infections, diet, smoking, pollution, activity - push the risk up or down.
  • Errors build up in the body over the years, which is why many diseases are more common with age.

๐Ÿซ€ What it does to the body

  • Each disease affects the body in its own way; the summary above explains this one.

๐Ÿงฑ Why it is hard to cure

  • The biology is often only partly understood.
  • A medicine has to be both effective and safe, and proving that in clinical trials takes years.

๐Ÿš€ What research is trying now

  • Studying which genes are linked to the disease - AI Cure shows them below, ranked by evidence.
  • Testing whether medicines approved for other diseases could help.

General information about every other disease, reviewed by people; it does not describe any one person. Below: the evidence for oral submucous fibrosis itself.

๐Ÿค–

AI briefing

Where the science on oral submucous fibrosis stands, from the evidence on this page

AI reads the targets, drugs, trials and papers below and writes where the science stands โ€” every claim cited. It is shared with everyone who opens oral submucous fibrosis.

๐ŸŽฏ

Top targets

Genes and proteins ranked by Open Targets evidence (0-1)
NR3C1 nuclear receptor subfamily 3 group C member 1PROTACothersmall molecule๐ŸงŠ AlphaFold structure โ†— 0.26
ZEB1 zinc finger E-box binding homeobox 1PROTAC๐ŸงŠ AlphaFold structure โ†— 0.08
EDNRA endothelin receptor type APROTACantibodyothersmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
AMELY amelogenin Y-linkedantibody๐ŸงŠ AlphaFold structure โ†— 0.07
AMELX amelogenin X-linkedantibody๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFA10 NADH:ubiquinone oxidoreductase subunit A10PROTACsmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFA6 NADH:ubiquinone oxidoreductase subunit A6PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFA12 NADH:ubiquinone oxidoreductase subunit A12PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFS1 NADH:ubiquinone oxidoreductase core subunit S1PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFA1 NADH:ubiquinone oxidoreductase subunit A1PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFC2 NADH:ubiquinone oxidoreductase subunit C2PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFS6 NADH:ubiquinone oxidoreductase subunit S6PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
MT-ND4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07
NDUFS8 NADH:ubiquinone oxidoreductase core subunit S8PROTACantibodysmall molecule๐ŸงŠ AlphaFold structure โ†— 0.07

Green labels: what the target is known to be druggable by. The score combines genetics, somatic mutations, drugs, expression and literature.

๐Ÿ’Š

Drugs and candidates

Every medicine linked to oral submucous fibrosis, by how far it has got
In phase 2 / 3 ยท 3
AloePhase 3
Betamethasone ValerateGlucocorticoid receptor agonistPhase 3
CurcuminPhase 3
Early trials ยท 2
MetforminMitochondrial complex I (NADH dehydrogenase) inhibitor; Mitochondrial glycerol-3-phosphatโ€ฆPhase 1/2
PirfenidonePhase 1/2
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy